Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Linezolid in the Treatment of Penicillin-Resistant Streptococcus Pneumoniae Pneumonia: An Open-Label, Non-Comparator Study

NCT00035269 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00035269
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00035269 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Linezolid in the Treatment of Penicillin-Resistant Streptococcus Pneumoniae Pneumonia: An Open-Label, Non-Comparator Study
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2001
Completion date
May 31, 2003
Enrollment
230 (actual)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

community acquired infections, gram-positive bacterial infections, pneumonia, pneumococcal